With its ability to target the abnormal metabolism of cancer cells, Sodium dichloroacetate (DCA) has shown promise as a metabolic cancer therapy.
In this article, the authors review a remarkable case report example to illustrate how over more than a four-year period, a stage 4 colon cancer case’s use of DCA and associated supports helped to stabilize her condition and enable her to continue to live a full life.
A success story based on a recent clinical observational study done in Canada. This time a young man with BRAF-positive, stage III recurrent melanoma, which failed to respond to a handful conventional treatments, managed to control his skin cancer with the help of DCA. Learn more about how he continued living a normal life while experiencing no debilitation.
